MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Post stroke dystonia and dystonic tremor: Clinical features and neuroimaging findings

    S. Pandey, P. Tater (New Delhi, India)

    Objective: To study the clinical features and neuroimaging findings of patients with post stroke dystonia and dystonic tremor. Background: Post stroke dystonia is a known…
  • 2019 International Congress

    Clinical Applications of Non-Invasive Neuromodulation associated with kinesiotherapy in focal dystonia patients: report of three cases

    C. Souza, J. Goulardins, D. Boari, S. Casagrande, J. Papaterra, C. Boffino, C. Tanaka, K. Monte-Silva (Sao Paulo, Brazil)

    Objective: The aim of our study was to evaluate further the potential role of Non-Invasive Neuromodulation combined with kinesiotherapy for treatment of focal dystonia (FD).…
  • 2019 International Congress

    After-effects Of Transcranial direct current stimulation (tDCS) On Hand Biomechanics In A Patient With Secondary Dystonia

    F. Yadolahi, M. Abedi (Tehran, Islamic Republic of Iran)

    Objective: The purpose of this study was to identify differences in kinematic arm motion after tDCS intervention based on principal component analysis that allows generating…
  • 2019 International Congress

    Successful late rehabilitation based on botulinum therapy

    T. Kuznetsova, A. Svetkina (Samara, Russian Federation)

    Objective: Hemiparesis of various severity is the most common stroke side effect. On average 30-40% of stroke survivors develop post-stroke spasticity. The best neuroplasticity enabling…
  • 2019 International Congress

    Abnormal thalamo-cortical functional connectivity patterns in Gilles de la Tourette Syndrome: a seed-based resting state fMRI study

    L. Zapparoli, M. Porta, F. Devoto, N. Tedone, D. Servello, E. Paulesu (Milan, Italy)

    Objective: Here we directly tested this hypothesis and we investigated the specific functional connectivity patterns of thalamic motor seeds in 24 GTS patients and 24…
  • 2019 International Congress

    The Prevalence of Essential Tremor in Edirne and Its Districts Concomitant Comorbid Conditions

    S. Güler, A. Caylan, N. Turan (Edirne, Turkey)

    Objective: We aimed to determine the prevalence and risk factors of Essential Tremor (ET) in Edirne and its districts, located in Western Thrace, which is…
  • 2019 International Congress

    Orthostatic jaw tremor, a diagnostic challenge

    R. Moraes, F. Sousa, P. Pereira, J. Freitas, L. Santos, J. Junior, M. Rocha (Sao Paulo, Brazil)

    Objective: To present a rare movement disorder of an orthostatic jaw tremor and a remarkable benefit from treatment with botulinum toxin A Background: Jaw tremor…
  • 2019 International Congress

    Is VIM-DBS in ET-plus patients as effective as in ET patients?

    J. Steffen, J. Petry-Schmelzer, T. Dembek, J. Becker, G. Fink, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)

    Objective: To compare the effect of deep brain stimulation (DBS) of the ventral intermediate nucleus (VIM) in patients with Essential Tremor (ET) and ET-plus (ET-p).…
  • 2019 International Congress

    Long-Term Outcomes in Patients with Tardive Dyskinesia who Were Early Responders with Valbenazine

    S. Factor, C. Comella, S. Marder, J. Burke, K. Farahmand, S. Siegert (Atlanta, GA, USA)

    Objective: To assess the long-term outcomes of once-daily valbenazine (VBZ) on tardive dyskinesia (TD) using a formal assessment (Abnormal Involuntary Movement Scale [AIMS]) in participants…
  • 2019 International Congress

    Re-emerging Neuroleptic Malignant Syndrome (NMS) without Re-introduced Neuroleptic in a Schizophrenia Patient: a Case Report

    D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: To report a case with re-emerging neuroleptic malignant syndrome (NMS) without re-introduced neuroleptic drugs. Background: Neuroleptic Malignant Syndrome (NMS) is a potentially fatal idiosyncratic…
  • « Previous Page
  • 1
  • …
  • 119
  • 120
  • 121
  • 122
  • 123
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley